Sort
16,300 grants matching “fatty liver disease”
FUNCTIONAL STUDIES OF FAAH
$310,936Benjamin F Cravatt · Scripps Research Institute, The · P01 · FY2008 · DA
Molecular mechanism of a master regulator of sterol homeostasis
$310,888Daniel Rosenbaum · Ut Southwestern Medical Center · R01 · FY2015 · GM
Regulation of Skeletal Muscle LKB1
$310,883William Winder · Brigham Young University · R01 · FY2010 · AR
Brain and Peripheral Metabolic Adaptations to Feeding Entrainment
$310,882Rexford S Ahima · University Of Pennsylvania · P01 · FY2015 · DK
Noninvasive assessment of portal hypertension and hepatic interstitial pressure with advanced magnetic resonance elastography
$310,878Meng Yin · Mayo Clinic Rochester · R01 · FY2025 · DK
Factors Controlling Metabolic Flux in the Liver by NMR Isotopomer Analysis
$310,860Shawn C Burgess · Ut Southwestern Medical Center · R01 · FY2010 · DK
A Simple Cellular Model for Lipodystrophy
$310,860Joel M Goodman · Ut Southwestern Medical Center · R01 · FY2010 · GM
CEACAM and Insulin Action
$310,844Sonia Michael Najjar · University Of Toledo Health Sci Campus · R01 · FY2013 · DK
p38 MAPK regulation of hepatic gluconeogenesis and lipogenesis
$310,800Wenhong Cao · The Hamner Institutes · R01 · FY2007 · DK
The role of GHS-R in macrophage reprogramming during meta-inflammation
$310,784Yuxiang Sun · Texas A&M Agrilife Research · R01 · FY2019 · DK
Alcohol Metabolism,Primate Evolution and Paleogenetics. An Inclusive Paradigm
$310,750Steven A Benner · Foundation For Applied Molecular Evolutn · R01 · FY2009 · AA
Acute pancreatitis and obesity
$310,613Giamila Fantuzzi · University Of Illinois At Chicago · R01 · FY2013 · DK
LXR and human ApoE isoform effects on AD phenotype: in vitro and in vivo models
$310,575Radosveta P Koldamova · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · AG
LXR and human ApoE isoform effects on AD phenotype: in vitro and in vivo models
$310,575Radosveta P Koldamova · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · AG
Roles of GM-CSF in Energy and Glucose Regulation
$310,526Randy J. Seeley · University Of Cincinnati · R01 · FY2007 · DK
AGEs/RAGE in Progressive NASH
$310,500Natalie J Torok · Palo Alto Veterans Instit For Research · R01 · FY2018 · DK
AGEs/RAGE in Progressive NASH
$310,500Natalie J Torok · Palo Alto Veterans Instit For Research · R01 · FY2019 · DK
Symptom Distress Mechanisms in Digestive Disorders
$310,283Wendy Henderson · National Institute Of Nursing Research · ZIA · FY2012 · NR
Regulation of Mitochondrial Dysfunction and Diet-Induced Obesity by ALCAT1
$310,200Yuguang Shi · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2009 · DK
Role of ATGL in hepatic energy metabolism
$310,108Douglas G Mashek · University Of Minnesota · R01 · FY2013 · DK
Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)
$310,083Anna Mae Elizabeth Diehl · Duke University · U01 · FY2021 · DK
Center for Childhood Obesity Prevention - Metabolism and Bioenergetics Core
$310,067Elisabet Borsheim · Arkansas Children'S Hospital Res Inst · P20 · FY2022 · GM
mTORC1-dependent regulation of the CycC/CDK8 complex
$310,007Jeffrey E Pessin · Albert Einstein College Of Medicine · R01 · FY2015 · DK
Microbiome as therapeutic target in alcoholic hepatitis
$309,999Bernd G. Schnabl · University Of California, San Diego · U01 · FY2018 · AA
Point-of Care MR Device to Estimate T1 Relaxation Time as a Biomarker of Liver Disease (resubmission)
$309,974Pablo J Prado · Livivos Inc. · R43 · FY2023 · EB